适应性酶响应性自我组装的多价值阿林配体,用于向心肌梗塞治疗
Jiejing Li1, Xudong Song1, Xu Liao1
1Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
概括
一种新的酶响应性自组装技术增强了对心肌梗塞病变的阿佩林传递. 这种策略通过促进血管生成和减少缺血后细胞死亡来改善心脏功能.
科学领域:
- 心血管研究研究心血管研究
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
背景情况:
- 心肌梗塞 (MI) 导致微血管功能障碍,加剧冠状动脉阻塞和损害心室功能.
- 抗激素系统通过改善血管功能和修复缺血性心肌,显示出对心脏病的治疗潜力.
- 天然阿佩林和当前类型的局限性包括短半衰期,低受体结合,和糟糕的向.
研究的目的:
- 开发一种酶响应性,可以在MI病变处自组装,以向传递阿林.
- 通过克服现有类型的局限性来提高基于阿佩林的疗法的疗效.
主要方法:
- 利用一种酶响应性的自组装技术.
- 设计了一种来响应在MI病变中过度表达的矩阵金属蛋白酶 (MMPs).
- 通过自我组装开发了一个超分子多价联体 (SAMP).
主要成果:
- 在MI病变中,SAMP在高MMP度下精确地呈现了阿佩林动机.
- 自组装延长了阿佩林的居住时间,并通过多价值增强了受体-连接体相互作用.
- SAMP显著促进了血管新生,减少了心肌细胞亡,并在缺血后改善了心脏功能.
结论:
- 酶响应性的自我组装策略提供精确有效的传递阿佩林到MI病变.
- 萨姆普在心脏病发作后恢复冠状动脉微血管功能和改善心脏功能方面显示出显著的治疗益处.
- 这种新的方法为心肌梗塞治疗提供了一个有前途的治疗策略.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420


